SEARCH NEWS & VIEWS


Looking Ahead: An Interview with Michael A. Marletta
Team Discovers a Brain Cell Malfunction in Schizophrenia
Pair of Grants Funds Study of Critical Component of Memory
Of Science, Spectrometry, and Senseis

NEWS & VIEWS HOME
PAST ISSUES
CAMPUS UPDATES
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT




FOLLOW US
1
Looking Ahead: An Interview with Michael A. Marletta

The new Scripps Research president speaks on topics including his background, priorities, and vision for the future.

Team Discovers a Brain Cell Malfunction in Schizophrenia

A study by the Thomas lab shows that DNA stays tightly wound in certain brain cells, suggesting drugs already in development for other diseases might eventually offer hope as a treatment for schizophrenia.

Pair of Grants Funds Study of Critical Component of Memory

Assistant Professor Sathyanaryanan Puthanveettil has been awarded funding to study a component of long-term memory formation.

Of Science, Spectrometry, and Senseis

Two new studies on an essential plant hormone also highlight the role played by Graham West, a postdoctoral fellow in the Griffin laboratory.

  • Jeopardy! Winnings Spur IBM and Scripps Research Collaboration to Fight Malaria
  • Team Finds Weak Spot on Deadly Ebolavirus
  • Scientists Identify New Class of Antimalarial Compounds
  • Team Achieves Critical Step for Opening Elusive Class of Compounds to Drug Discovery
  • From Curiosity to Click Chemistry: K. Barry Sharpless Forges His Own Way
  • The Molecular Architect: A Profile of Julius Rebek, Jr.
  • Scientists Discover Inflammation Is Controlled Differently in Brain and Other Tissues
  • From Immune System Discoveries to Nobel Message on Cell Phone
  • Paul Thompson: Uncovering the Mechanisms of Autoimmune Disease
  • Scientists Find Clue to Cause of Childhood Hydrocephalus
  • Team Discovers Treatable Mechanism Responsible for Often Deadly Response to Flu
  • Scientists Produce First Stem Cells From Endangered Species in Hopes of Strengthening Populations
  • Scientists Reengineer an Antibiotic to Overcome Dangerous Antibiotic-Resistant Bacteria